- A generic information System for Cycler Home Peritoneal Dialysis that helps doctors & nurses to monitor remotely & daily treatment progress of PD patients.
- A cost-effective monitoring system for home CAPD that allow care team to check & adjust the treatment remotely & in a timely fashion.
- RenalCan had previously granted patents on alternative osmotic agent. This new osmotic agent for peritoneal dialysis which not only benefit patient with renal failure but also
particularly benefit diabetic patients.
- RenalCan has been granted patents in Canada, Australia, US & Europe of a new manufacturing method to produce dialysis solution which will decrease risk & cost of freight &
product.
RenalCan 護爾康生物科技
Print